Methotrexate induces apoptosis in CaSki and NRK cells and influences the organization of their actin cytoskeleton

European Journal of Pharmacology

Volumn 613, Issue 1-3, 2009, Pages 24-33

  Mazur, Antonina Joanna ^a,b   Nowak, Dorota ^b   Mannherz, Hans Georg ^a   Malicka Błaszkiewicz, Maria ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Actin cytoskeleton; Apoptosis; Caspase 3; Methotrexate

Indexed keywords

ACTIN; DIHYDROFOLATE REDUCTASE INHIBITOR; FOLIC ACID ANTAGONIST; LIPOCORTIN 5; METHOTREXATE; PHOSPHATIDYLSERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DNA FRAGMENTATION; DRUG MECHANISM; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; UTERINE CERVIX CANCER;

ACTINS; ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; FOLIC ACID ANTAGONISTS; HUMANS; METHOTREXATE;

EID: 65749087471     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.04.020     Document Type: Article

References (52)

1. Allegra C.J., Drake J.C., Jolivet J., and Chabner P.A. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4881-4885
2. Andersson S.E., Johansson L.-H., Lexmüller K., and Ekström G.M. Anti-arthritic effect of methotrexate: is it really mediated by adenosine?. Eur. J. Pharm. Sci. 9 (2000) 333-343
3. Barry M.A., Behnke C.A., and Eastman A. Activation of programmed cell death by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40 (1990) 2353-2362
4. Bokhari M., Carnachan R.J., Cameron N.R., and Przyborski S.A. Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J. Anat. 211 (2007) 567-576
5. Caltayud S., Warner T.D., and Mitchel J.A. Modulation of colony stimulating factor release and apoptosis in human colon cancer cells by anticancer drugs. Br. J. Cancer 86 (2002) 1316-1321
6. Chabner P.A., Allegra C.J., Curt G.A., Clendeninn N.J., Baram J., Koisumi S., Drake J.C., and Jolivet J. Polyglutamation of methotrexate. Is methotrexate a prodrug?. J. Clin. Invest. 76 (1985) 907-912
7. Collins R.J., Harmon B.V., Gobe G.C., and Kerr J.F.R. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol. 61 (1992) 451-453
8. Collins J.A., Schnadl C.A., Young K.K., Vesely J., and Willingham M.C. Major DNA fragmentation is a late event in apoptosis. J. Histochem. Cytochem. 45 (1997) 923-934
9. Cronstein B.N., Eberle M.A., Gruber H.E., and Levin R.I. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 2441-2445
10. Cutolo M., Bisso A., Sulli A., Felli L., Briata M., Pizzorini C., and Villaggio B. Antiproliferative and antiinflammatory effect of methotrexate on cultured differentiating myeloid monocytic cells (THP1) but not on synovial macrophages from patients with rheumatoid arthritis. J. Rheumatol. 27 (2000) 2551-2557
11. De Silva C.P., De Oliviera C.R., and De Conceicao P.L. Apoptosis is a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem. Pharmacol. 51 (1996) 1331-1340
12. El Alaoui S., Lawry J., and Griffin M. The cell cycle and induction of apoptosis in hamster fibrosarcoma cell line treated with anticancer drugs: its importance to solid cancer chemotherapy. J. Neuro-Oncol. 31 (1997) 195-207
13. Genestier L., Paillot R., Quemeneur L., Izeradjene K., and Revillard J.P. Mechanism of action of methotrexate. Immunopharmacology 47 (2000) 247-257
14. Giganti A., and Friederich E. The actin cytoskeleton as a therapeutic target: state of the art and future directions. Prog. Cell Cycle Res. 5 (2003) 511-525
15. Gourlay C.W., and Ayscough K.R. The actin cytoskeleton in ageing and apoptosis. FEMS Yeast Res. 5 (2005) 1193-1198
16. Hattangadi D.K., DeMasters G.A., Walker T.D., Jones K.R., Di X., Newsham I.F., and Gewitz D.A. Influence of p53 and caspase activity on cell death and senescence in response to methotrexate in the breast cancer cell. Biochem. Pharmacol. 68 (2004) 1699-1708
17. Hayot C., Debeir O., Van Ham P., Van Damme M., Kiss R., and Decaestecker C. Characterization of the activities of actin-affecting drugs on cancer cell migration. Toxicol. Appl. Pharmacol. 211 (2006) 30-40
18. Herman S., Zurgil N., and Deutsch M. Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines. Inflamm. Res. 54 (2005) 273-280
19. Holdenrieder S., and Stiebe P. Apoptotic markers in cancer. Clin. Biochem. 37 (2004) 605-617
20. Jolivet J., Cowan K.H., Curt G.A., Clendenin N.J., and Chabner B.A. The pharmacology and clinical use of methotrexate. N. Engl. J. Med. 3 (1983) 1094-1104
21. Jordan M.A., and Wilson L. Microtubules and actin filaments: dynamic target for cancer chemotherapy. Curr. Opin. Cell Biol. 10 (1998) 123-130
22. Kaufmann S. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, captothecin and the other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49 (1989) 5870-5878
23. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., Mcgarry T.J., Kirschner M.W., Koths K., Kwiatkowski D.J., and Williams L.T. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278 (1997) 294-298
24. Kruidering M., Van de Water B., Zhan Y., Baelde J.J., De Heer E., Mulder G.J., Stevens J.L., and Nagelkerke J.F. Cisplatin effect on F-actin and matrix proteins precede renal tubular cell detachment and apoptosis in vitro. Cell Death Differ. 5 (1998) 601-614
25. Laurence J.E., and Sandborn W.J. Methotrexate for inflammatory bowel disease. Pharmacology and preliminary results. Mayo Clin. Proc. 71 (1996) 69-80
26. Mannherz H.G., Gonsior S.M., Gremm D., Wu X., Pope B.J., Wartosch L., and Weeds A.G. Activated cofilin colocalises with Arp2/3 complex in apoptotic blebs during programmed cell death. Eur. J. Cell Biol. 84 (2005) 503-515
27. Mannherz H.G., Gonsior S.M., Wu X., Polzar B., Pope B.J., Wartosch L., and Weeds A.G. Dual effects of staurosporine on A431 and NRK cells: microfilament disassembly and uncoordinated lamellipodial activity followed by cell death. Eur. J. Cell Biol. 85 (2006) 785-802
28. Mannherz H.G., Mach M., Nowak D., Malicka-Błaszkiewicz M., and Mazur A. Lamellipodial and amoeboid cell locomotion: the role of actin-cycling and bleb formation. Biophys. Rev. Lett. 2 (2007) 5-22
29. Mashima T., Naito M., and Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 18 (1999) 2423-2430
30. Merkle C.J., Moore I.M., Penton B.S., Torres B.J., Cueny R.K., Schaeffer R.C., and Montgomery D.W. Methotrexate causes apoptosis in postmitotic endothelial cells. Biol. Res. Nurs. 2 (2000) 4-14
31. Mills J.C., Sone N.L., and Pittman R.N. Extranuclear apoptosis: the role of the cytoplasm in the execution phase. J. Cell Biol. 146 (1999) 703-707
32. Napirei M., Wulf S., and Mannherz H.G. Chromatin breakdown during necrosis by serum Dnase 1 and the plasminogen system. Arthritis Rheum. 50 (2004) 1873-1883
33. Odaka C., Sanders M.L., and Crews P. Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway. Clin. Diagn. Lab. Immunol. 7 (2000) 947-952
34. Otrocka M., Verschueren H., and Malicka-Błaszkiewicz M. The effect of methotrexate on actin and invasiveness of hepatoma Morris 5123 cells in culture. Acta Biochim. Pol. 48 (2001) 1051-1060
35. Paddenberg R., Loos S., Schöneberger H.J., Wulf S., Müller M., Iwig M., and Mannherz H.G. Serum withdrawal induces a redistribution of intracellular gelsolin towards F-actin in NIH 3T3 fibroblasts preceding apoptotic cell death. Eur. J. Cell Biol. 80 (2001) 366-378
36. Papaconstantinou H., Xie C., Zhang W., Ansari N., Hellmich M., Townsend C., and Ko T. The role of caspase in methotrexate-induced gastrointestinal toxicity. Surgery 130 (2001) 859-865
37. Ranganathan P. An update on methotrexate pharmacogenetics in rheumatoid arthritis. Pharmacogenomics 9 (2008) 439-451
38. Rao J.Y., and Li N. Microfilament actin remodelling as a potential target for cancer drug development. Curr. Cancer Drug Targets 4 (2004) 267-283
39. Rao J.Y., Jin Y., Zheng Q., Cheng J., Tai J., and Hemstreet G. Alteration of the actin polymerization status as an apoptotic morphological effector in HL60 cells. J. Cell. Biochem. 75 (1999) 686-697
40. Rosenblum M., and Shivers R. Rings of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere. Comp. Biochem. Physiol. 125 (2000) 121-131
41. Rufini S., Rainaldi G., Abbracchio M.A., Fiorentini P., Capri M., Franceschi C., and Malorni W. Actin cytoskeleton as a target for 2-chloro adenosine: evidence for induction of apoptosis in C2C12 myoblastic cells. Biochem. Biophys. Res. Commun. 238 (1997) 361-366
42. Ruiz-Ruiz M.C., and Lopez-Rivas A. p53 mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast cancer cells. Cell Death Differ. 6 (1999) 271-280
43. Saraste A., and Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 45 (2000) 528-537
44. Takemura Y., and Jackman A.L. Folate-based thymidylate synthase inhibitors in cancer chemotherapy. Anticancer Drugs 8 (1997) 3-16
45. Tsurusawa M., Niwa M., Katano N., and Fujimoto T. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotexate-treated mouse L1210 leukemia cells. Cancer Res. 48 (1988) 4288-4293
46. Tsuruta S., Setsuko I., and Mikawa H. Effects of adenosine and its analogues on actin polymerization in human polymorphonuclear leucocytes. Clin. Exp. Pharmacol. Physiol. 20 (1993) 89-94
47. Utsumi T., Sakurai N., Nakano K., and Ishisaka R. C-terminal 15-kDa fragment of cytoskeletal actin is posttranslationally N-myristoylated upon caspase-mediated cleavage and targeted to mitochondria. FEBS Lett. 539 (2003) 37-44
48. Walling J. From methotrexate to pemetrexed and beyond. A review of pharmacodynamic and clinical properties of antifolates. Invest. New Drugs 24 (2006) 37-77
49. Warren R.B., Chalmers R.J.G., Griffiths C.E.M., and Menter A. Methotrexate for psoriasis in the area of biological therapy. Clin. Exp. Dermatol. 33 (2008) 551-554
50. Weinblatt M.E., Coblyn J.S., Fox D.A., Fraser P.A., Holdsworth D.E., Glass D.N., and Trendham D.E. Efficacy of low dose methotrexate in rheumatoid arthritis. N. Engl. J. Med. 321 (1985) 818-822
51. Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev. 11 (1992) 95-103
52. Yu J., and Zhang L. Apoptosis in human cancer cells. Curr. Opin. Oncol. 16 (2004) 19-24